Allergy Therapeutics plc Earns "Buy" Rating from Panmure Gordon

‘s stock had its “buy” rating restated by Panmure Gordon in a report issued on Tuesday, Analyst Ratings Network.com reports. They presently have a GBX 47 price objective on the stock.